This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Allele Biotechnology & Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Nathan C. Shaner: Innovator in Antibody Selection Technology
Introduction
Nathan C. Shaner is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the selection of antibodies and antibody fragments. His innovative methods have the potential to revolutionize how antibodies are identified and utilized in various applications.
Latest Patents
Nathan C. Shaner holds a patent for "Methods of selecting antibodies and antibody fragments." This multi-step method enhances the efficiency of selecting antibodies against specific immunogens. The technology not only increases the likelihood of finding effective antibodies but also ensures that the selected antibodies are the most abundant ones induced by the immunogen. This characteristic provides a higher potential for specificity and affinity, making it a valuable tool in numerous fields that involve antibody or T cell receptor selection.
Career Highlights
Shaner is currently associated with Allele Biotechnology & Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach and practical applications in the biotechnology sector.
Collaborations
Throughout his career, Nathan has collaborated with notable colleagues, including Gerard G. Lambert and Jiwu Wang. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.
Conclusion
Nathan C. Shaner is a key figure in the field of antibody selection technology, with a patent that showcases his innovative approach to improving efficiency and specificity. His contributions are poised to have a lasting impact on biotechnology and related fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile